ATE297753T1 - Verfahren und mittel zur schmerzbehandlung - Google Patents

Verfahren und mittel zur schmerzbehandlung

Info

Publication number
ATE297753T1
ATE297753T1 AT97949809T AT97949809T ATE297753T1 AT E297753 T1 ATE297753 T1 AT E297753T1 AT 97949809 T AT97949809 T AT 97949809T AT 97949809 T AT97949809 T AT 97949809T AT E297753 T1 ATE297753 T1 AT E297753T1
Authority
AT
Austria
Prior art keywords
pain treatment
amylin
pain
conjunction
disclosed
Prior art date
Application number
AT97949809T
Other languages
English (en)
Inventor
Andrew A Young
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE297753T1 publication Critical patent/ATE297753T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97949809T 1996-12-16 1997-12-12 Verfahren und mittel zur schmerzbehandlung ATE297753T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/767,169 US5677279A (en) 1996-12-16 1996-12-16 Methods and compositions for treating pain with amylin or agonists thereof
PCT/US1997/023015 WO1998026796A1 (en) 1996-12-16 1997-12-12 Methods and compositions for treating pain

Publications (1)

Publication Number Publication Date
ATE297753T1 true ATE297753T1 (de) 2005-07-15

Family

ID=25078691

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97949809T ATE297753T1 (de) 1996-12-16 1997-12-12 Verfahren und mittel zur schmerzbehandlung

Country Status (9)

Country Link
US (1) US5677279A (de)
EP (1) EP0964695B1 (de)
AT (1) ATE297753T1 (de)
AU (1) AU727688B2 (de)
CA (1) CA2274967C (de)
DE (1) DE69733575T2 (de)
ES (1) ES2244010T3 (de)
WO (1) WO1998026796A1 (de)
ZA (1) ZA9711255B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1629849E (pt) * 1997-01-07 2013-07-09 Amylin Pharmaceuticals Llc Composições farmacêuticas que compreendem exendinas e seus agonistas
US7101853B2 (en) 1997-05-06 2006-09-05 Amylin Pharmaceuticals, Inc. Method for treating or preventing gastritis using amylin or amylin agonists
WO2001028539A2 (en) * 1999-10-19 2001-04-26 Glaxo Group Limited Agent for treating cephalic pain
AU1037301A (en) * 1999-10-19 2001-04-30 Glaxo Group Limited Therapy of cephalic pain
GB9924717D0 (en) * 1999-10-19 1999-12-22 Glaxo Group Ltd Diagnostic
US8168233B2 (en) * 2002-10-18 2012-05-01 Amylin Pharmaceuticals, Inc. Treatment of pancreatitis with amylin
DE602005021858D1 (de) 2004-02-11 2010-07-29 Amylin Pharmaceuticals Inc Peptide der amylin familie, verfahren zu deren herstellung und verwendung
US7399744B2 (en) * 2004-03-04 2008-07-15 Amylin Pharmaceuticals, Inc. Methods for affecting body composition
US7692013B2 (en) * 2004-10-27 2010-04-06 Mallinkrodt Inc. Method for separation and purification of hydrocodone by preparative chromatography
US7671023B2 (en) 2005-03-31 2010-03-02 Amylin Pharmaceuticals, Inc. Amylin agonist for treating depression, anxiety disorder and schizophrenia
EA035791B1 (ru) 2015-03-18 2020-08-11 Зилэнд Фарма А/С Аналоги амилина
AR109514A1 (es) 2016-09-09 2018-12-19 Zealand Pharma As Análogos de amilina
MX2024005969A (es) 2022-05-30 2024-06-11 Zealand Pharma As Formulaciones liquidas de analogos de amilina.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
US5367052A (en) * 1987-04-27 1994-11-22 Amylin Pharmaceuticals, Inc. Amylin peptides
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5175145A (en) * 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
US5721207A (en) * 1995-04-18 1998-02-24 Innapharma, Inc. Method for treatment of pain

Also Published As

Publication number Publication date
CA2274967A1 (en) 1998-06-25
EP0964695A1 (de) 1999-12-22
AU727688B2 (en) 2000-12-21
DE69733575T2 (de) 2006-05-04
WO1998026796A1 (en) 1998-06-25
US5677279A (en) 1997-10-14
EP0964695B1 (de) 2005-06-15
ZA9711255B (en) 1998-09-02
EP0964695A4 (de) 2001-05-23
DE69733575D1 (de) 2005-07-21
AU7735698A (en) 1998-07-15
ES2244010T3 (es) 2005-12-01
CA2274967C (en) 2009-10-13

Similar Documents

Publication Publication Date Title
DE69733575D1 (de) Verfahren und mittel zur schmerzbehandlung
AU3118699A (en) Apparatus and method for therapeutic treatment of low back pain
FI960493A7 (fi) Menetelmä ja laite terapeuttiseen elektromagneettiseen hoitoon
PL341640A1 (en) Apparatus for and method of therapeutically treating body tissue with electricity or drugs
AU2498300A (en) Nerve stimulation method and apparatus for pain relief
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
DE69807538D1 (de) Vorrichtung und Verfahren zur Behandlung von Gewebe
DE69734751D1 (de) Bestrahlungsbehandlungsvorrichtung und Verfahren
AU4224600A (en) Composition and method for treatment of inflammation and pain in mammals
SE9603725D0 (sv) New teatment
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE69715922D1 (de) Verfahren und einrichtung zur behandlung von tabak
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
NO984446L (no) FremgangsmÕte for behandling av smerte
PL328959A1 (en) Method of treating or preventing interstitial cystitis
NO982582L (no) Fremgangsmaate for behandling av smerte
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
IL120495A0 (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
BA98363A (bs) Postupak i uredaj za tretiranje koze i tome slicno
NO984198L (no) FremgangsmÕte for behandling av aggresjon
DE69517954D1 (de) Vorrichtung und Verfahren zur Behandlung von Abwasser mittels biologisch aktiver Holzkohle
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
UA36261A (uk) Спосіб лікування простої шизофренії з суїцидальною поведінкою

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties